SGLT2 inhibitor treatment may now be considered in broader T2DM population
AHA 2018 - Chicago, IL, VS3' education - Nov. 11, 2018 - Steve Wiviott, MD - Boston, MA, VS.
This video was recorded at the congress of the American Heart Association on November 10, 2018, in Chicago, IL, USA.
Steve Wiviott, MD, Brigham and Women's Hospital, Boston, MA, VS.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.